Novotech appoints DatelineMedia (USA) as Communications
December 7, 2004 by admin
Filed under Company News, Company News 2004
Dec 7, 2004 – San Francisco, CA – Novotech, Australia’s leading clinical research organization (CRO), has appointed DatelineMedia Communications (USA) as its agency of record for PR and media strategy in the U.S.
Alek Safarian, Novotech CEO, said editorial media coverage played a significant role in the company’s business development program in the U.S. and DatelineMedia had already secured an impressive spread of Novotech features in leading U.S industry media.
“We are firm believers in the power of editorial news coverage, and judging by our success in the U.S. market this strategy is paying off,” said Safarian.
DatelineMedia Communications (USA) LLc is a U.S. based national communications and media strategy firm with direct connections into the biotech, life sciences and investment media.
Founded in 2002 by U.S. and Australian journalists, the Agency has grown from its head office in San Francisco to include offices in New York and Sydney, with affiliates in Los Angeles and Washington D.C. www.datelinemedia.com
About Novotech – Unsurpassed Local Knowledge and Network:
Increasingly, U.S. companies are turning to Australia to expedite the pace, and reduce the cost, of clinical trials, while maintaining the high standard of research that U.S. authorities demand. A 2001 Ernst and Young benchmarking study found that clinical research costs may be as much as 30 percent lower in Australia than in the United States and Europe.
In addition, Australian regulatory procedures often enable a trial to begin in as little as 2-3 months from the initiation of the approval process. This compares favorably to usual timelines in major Western countries.
As the largest independent CRO in Australia, Novotech offers a level of flexibility and local knowledge that is virtually unmatched among other contract research organizations in the region. This has helped Novotech develop a strong client base in the United States and Europe.
Headquartered in Sydney, Novotech is focused on the Australian and New Zealand markets but has worldwide reach through the company’s subsidiary in the United Kingdom and through key external partnerships and strategic alliances in North America and other regions.
